December 29, 2015
Add Us On GoogleAdd SciAmScientists-Find-New-Drug-Targets-for-Psoriasis
Psoriasis is a chronic inflammatory skin disorder that affects about 2-3% of the population. It is triggered by the immune system, and new insights into immune processes have thrown up a number of exciting drug targets.
This article was first published by Nature Reviews Drug Discovery, which has full responsibility for all editorial content. It is a NatureVideo production and was reproduced with permission. The editorial advisor is Manfred Kopf; animation by Arkitek Scientific. This content is editorially independent of sponsors.
Produced with support from Eli Lilly and Company.
Join Our Community of Science Lovers!
It’s Time to Stand Up for Science
If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.
I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.
If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.
In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.
There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.
